カテゴリー： 世界, 医療/バイオ, Grand View Research

世界の新生児スクリーニング市場（2023-2030）：技術別（タンデム質量分析、パルスオキシメトリ）、検査種類別、製品別（装置、試薬）、地域別

【英語タイトル】Newborn Screening Market Size, Share & Trends Analysis Report By Technology (Tandem Mass Spectrometry, Pulse Oximetry), By Test Type, By Product (Instruments, Reagents), By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23NOV176）・商品コード：GRV23NOV176
・発行会社（調査会社）：Grand View Research
・発行日：2023年9月
・ページ数：180
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：臨床診断
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥880,600見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,028,600見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,324,600見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

新生児スクリーニング市場の成長と動向
Grand View Research, Inc.の最新レポートによると、世界の新生児スクリーニング市場規模は2030年までに14億米ドルに達する見込みです。同市場は2023年から2030年にかけてCAGR 7.54%で拡大する見込みです。新生児スクリーニング市場の成長は、有利な償還政策や政府支援プログラム、効率的なスクリーニング検査の開発に注力する主要企業の存在が主な要因です。また、中国やインドなどの人口大国における出生率の高さと可処分所得の高さは、市場を積極的に牽引すると予想される要因です。

Indian Paediatrics Report 2022によると、NBSは公衆衛生予防の定番となっており、そのパネルは常に増加しています。特定のDBSベースの代謝検査ツールは、NBSにおいて引き続き重要です。遺伝学的検査とゲノム検査は、科学の進歩により効果的なツールとなりました。しかし、どちらにも利点と欠点があります。一部の遺伝性疾患に対する現在のNBSの効率は、代謝データと遺伝子データの統合分析によって向上し、より多くの罹患者が早期診断と治療を受けられるようになり、予後が改善されるでしょう。

さらに、政府のプログラムや法律も、市場成長を促進するための有利な環境を作り出しています。新生児スクリーニング・プログラムは、世界の子供たちの健康を守るためにWHOによって推奨されました。このプログラムの下、日本の産科婦人科学会（JSOG）、米国保健福祉省新生児と小児の遺伝性疾患に関する長官諮問委員会（SACHDNC）、英国（PEACH）、March of Dimesのような擁護団体によって、数多くの政策や取り組みが行われています。

さらに2022年6月、ノバルティスは米国血液学会と戦略的パートナーシップを締結し、アフリカ6カ国の新生児の鎌状赤血球症に取り組んでいます。ASHのConsortium on Newborn Screening in Africa（アフリカにおける新生児スクリーニングに関するコンソーシアム：CONSA）は、ガーナ、リベリア、ケニア、ナイジェリア、タンザニア、ウガンダ、ザンビアなどの国々の複数の施設で早期介入とスクリーニングプログラムを提供する予定です。

さらに、新生児スクリーニングの分野における技術革新への注目が高まることで、市場の成長が促進される見込みです。例えば、2022年8月、トリビトロン・ヘルスケアは、新生児スクリーニング、ゲノミクス、分子診断、メタボロミクスのためのセンター・オブ・エクセレンスを立ち上げました。新生児スクリーニング用のELISA、PCR、IVD CE承認キットに基づくがんマーカーは、この施設で製造される予定です。

新生児スクリーニング市場レポートハイライト

- 検査タイプ別では、乾燥血液スポット検査分野が2022年の新生児スクリーニング市場全体を支配しました。50以上の疾患の診断のために、出生後24～48時間以内にスクリーニングカードで新生児のかかとから血液を採取することを、かかと刺し検査または乾燥血液スポット（DBS）検査と呼びます。

- 技術別では、タンデム質量分析が、費用対効果、高い適用性、技術的アップグレードによる高い需要により、2022年の市場全体を支配しました。

- 2022年の新生児スクリーニング市場では、アジア太平洋地域が最大のシェアを占めました。インフラと医療計画の改善、および拡大のための新たな機会の利用可能性が、予測期間にわたって地域市場の需要を促進する上で大きな役割を果たす見込みです。

- 業界各社は、持続可能性を確保するため、戦略的パートナーシップやM&Aに積極的に取り組んでいます。例えば、トリビトロン・ヘルスケアとアジレント・テクノロジーは、LC-MS/MSプラットフォームに基づく高精度の体外診断分野で提携を開始しました。

第1章. 調査方法・範囲
第2章. エグゼクティブサマリー
第3章. 市場変動・動向・範囲
第4章. 世界の新生児スクリーニング市場：技術別分析
第5章. 世界の新生児スクリーニング市場：検査タイプ別分析
第6章. 世界の新生児スクリーニング市場：製品別分析
第7章. 世界の新生児スクリーニング市場：地域別分析
第8章. 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Test type segment
1.1.1.2. Product segment
1.1.1.3. Technology segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.4.1. Objective – 1
1.4.2. Objective – 2
1.4.3. Objective – 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Secondary Sources
1.6.4. Primary research
1.7. Information or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Test Type and Product Snapshot
2.3. Technology Snapshot
2.4. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Newborn Screening Market: Technology Analysis
4.1. Newborn Screening Market: Technology Movement Analysis
4.2. Tandem mass spectrometry
4.2.1. Tandem mass spectrometry market, 2018 – 2030 (USD Million)
4.3. Pulse oximetry
4.3.1. Pulse oximetry market, 2018 – 2030 (USD Million)
4.4. Enzyme based assay
4.4.1. Enzyme based assays market, 2018 – 2030 (USD Million)
4.5. DNA assays
4.5.1. DNA assays market, 2018 – 2030 (USD Million)
4.6. Electrophoresis
4.6.1. Electrophoresis market, 2018 – 2030 (USD Million)
4.7. Others
4.7.1. Other technologies market, 2018 – 2030 (USD Million)
Chapter 5. Newborn Screening Market: Test Type Analysis
5.1. Newborn Screening Market: Test Type Movement Analysis
5.2. Dry blood spot test
5.2.1. Dry blood spot test market, 2018 – 2030 (USD Million)
5.3. CCHD
5.3.1. CCHD test market, 2018 – 2030 (USD Million)
5.4. Hearing screen
5.4.1. Hearing screen test market, 2018 – 2030 (USD Million)
Chapter 6. Newborn Screening Market: Product Analysis
6.1. Newborn Screening Market: Product Movement Analysis
6.2. Instruments
6.2.1. Instruments market, 2018 – 2030 (USD Million)
6.3. Reagents
6.3.1. Reagents market, 2018 – 2030 (USD Million)
Chapter 7. Newborn Screening Market: Regional Analysis
7.1. Newborn Screening Market Share By Region, 2022 & 2030
7.2. North America
7.2.1. North America Newborn Screening Market, 2018 – 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Target Disease Prevalence
7.2.2.3. Competitive Scenario
7.2.2.4. Regulatory Framework
7.2.2.5. U.S. Newborn Screening Market, 2018 – 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Target Disease Prevalence
7.2.3.3. Competitive Scenario
7.2.3.4. Regulatory Framework
7.2.3.5. Canada Newborn Screening Market, 2018 – 2030 (USD Million)
7.3. Europe
7.3.1. Europe Newborn Screening Market, 2018 – 2030 (USD Million)
7.3.2. UK
7.3.2.1. Key Country Dynamics
7.3.2.2. Target Disease Prevalence
7.3.2.3. Competitive Scenario
7.3.2.4. Regulatory Framework
7.3.2.5. UK Newborn Screening Market, 2018 – 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Key Country Dynamics
7.3.3.2. Target Disease Prevalence
7.3.3.3. Competitive Scenario
7.3.3.4. Regulatory Framework
7.3.3.5. Germany Newborn Screening Market, 2018 – 2030 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Target Disease Prevalence
7.3.4.3. Competitive Scenario
7.3.4.4. Regulatory Framework
7.3.4.5. France Newborn Screening Market, 2018 – 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Target Disease Prevalence
7.3.5.3. Competitive Scenario
7.3.5.4. Regulatory Framework
7.3.5.5. Italy Newborn Screening Market, 2018 – 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Target Disease Prevalence
7.3.6.3. Competitive Scenario
7.3.6.4. Regulatory Framework
7.3.6.5. Spain Newborn Screening Market, 2018 – 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Target Disease Prevalence
7.3.7.3. Competitive Scenario
7.3.7.4. Regulatory Framework
7.3.7.5. Denmark Newborn Screening Market, 2018 – 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Target Disease Prevalence
7.3.8.3. Competitive Scenario
7.3.8.4. Regulatory Framework
7.3.8.5. Sweden Newborn Screening Market, 2018 – 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Target Disease Prevalence
7.3.9.3. Competitive Scenario
7.3.9.4. Regulatory Framework
7.3.9.5. Norway Newborn Screening Market, 2018 – 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Newborn Screening Market, 2018 – 2030 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Target Disease Prevalence
7.4.2.3. Competitive Scenario
7.4.2.4. Regulatory Framework
7.4.2.5. Japan Newborn Screening Market, 2018 – 2030 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Competitive Scenario
7.4.3.4. Regulatory Framework
7.4.3.5. China Newborn Screening Market, 2018 – 2030 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Competitive Scenario
7.4.4.4. Regulatory Framework
7.4.4.5. India Newborn Screening Market, 2018 – 2030 (USD Million)
7.4.5. Australia
7.4.5.1. Key Country Dynamics
7.4.5.2. Target Disease Prevalence
7.4.5.3. Competitive Scenario
7.4.5.4. Regulatory Framework
7.4.5.5. Australia Newborn Screening Market, 2018 – 2030 (USD Million)
7.4.6. Thailand
7.4.6.1. Key Country Dynamics
7.4.6.2. Target Disease Prevalence
7.4.6.3. Competitive Scenario
7.4.6.4. Regulatory Framework
7.4.6.5. Thailand Newborn Screening Market, 2018 – 2030 (USD Million)
7.4.7. South Korea
7.4.7.1. Key Country Dynamics
7.4.7.2. Target Disease Prevalence
7.4.7.3. Competitive Scenario
7.4.7.4. Regulatory Framework
7.4.7.5. South Korea Newborn Screening Market, 2018 – 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Newborn Screening Market, 2018 – 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Target Disease Prevalence
7.5.2.3. Competitive Scenario
7.5.2.4. Regulatory Framework
7.5.2.5. Brazil Newborn Screening Market, 2018 – 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Competitive Scenario
7.5.3.4. Regulatory Framework
7.5.3.5. Mexico Newborn Screening Market, 2018 – 2030 (USD Million)
7.5.4. Argentina
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Competitive Scenario
7.5.4.4. Regulatory Framework
7.5.4.5. Argentina Newborn Screening Market, 2018 – 2030 (USD Million)
7.6. MEA
7.6.1. MEA Newborn Screening Market, 2018 – 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Target Disease Prevalence
7.6.2.3. Competitive Scenario
7.6.2.4. Regulatory Framework
7.6.2.5. South Africa Newborn Screening Market, 2018 – 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Competitive Scenario
7.6.3.4. Regulatory Framework
7.6.3.5. Saudi Arabia Newborn Screening Market, 2018 – 2030 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Target Disease Prevalence
7.6.4.3. Competitive Scenario
7.6.4.4. Regulatory Framework
7.6.4.5. UAE Newborn Screening Market, 2018 – 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Target Disease Prevalence
7.6.5.3. Competitive Scenario
7.6.5.4. Regulatory Framework
7.6.5.5. Kuwait Newborn Screening Market, 2018 – 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Share Analysis, 2022
8.4. Company Profiles/Listing
8.4.1. Covidien Plc.
8.4.1.1. Overview
8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. AB SCIEX
8.4.2.1. Overview
8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Bio-Rad Laboratories
8.4.3.1. Overview
8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Agilent Technologies
8.4.4.1. Overview
8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Masimo Corporation
8.4.5.1. Overview
8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Waters Corporation
8.4.6.1. Overview
8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Natus Medical
8.4.7.1. Overview
8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Trivitron Healthcare
8.4.8.1. Overview
8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. GE Lifesciences
8.4.9.1. Overview
8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. PerkinElmer Inc
8.4.10.1. Overview
8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives

List of Tables

Table 1 List of abbreviations
Table 2 Global newborn screening market, by product, 2018 - 2030 (USD Million)
Table 3 Global newborn screening market, by technology, 2018 - 2030 (USD Million)
Table 4 Global newborn screening market, by test type, 2018 - 2030 (USD Million)
Table 5 Global newborn screening market, by region, 2018 - 2030 (USD Million)
Table 6 North America newborn screening market, by country, 2018 - 2030 (USD Million)
Table 7 North America newborn screening market, by product, 2018 - 2030 (USD Million)
Table 8 North America newborn screening market, by technology, 2018 - 2030 (USD Million)
Table 9 North America newborn screening market, by test type, 2018 - 2030 (USD Million)
Table 10 U.S. newborn screening market, by product, 2018 - 2030 (USD Million)
Table 11 U.S. newborn screening market, by technology, 2018 - 2030 (USD Million)
Table 12 U.S. newborn screening market, by test type, 2018 - 2030 (USD Million)
Table 13 Canada newborn screening market, by product, 2018 - 2030 (USD Million)
Table 14 Canada newborn screening market, by technology, 2018 - 2030 (USD Million)
Table 15 Canada newborn screening market, by test type, 2018 - 2030 (USD Million)
Table 16 Europe newborn screening market, by country, 2018 - 2030 (USD Million)
Table 17 Europe newborn screening market, by product, 2018 - 2030 (USD Million)
Table 18 Europe newborn screening market, by technology, 2018 - 2030 (USD Million)
Table 19 Europe newborn screening market, by test type, 2018 - 2030 (USD Million)
Table 20 UK newborn screening market, by product, 2018 - 2030 (USD Million)
Table 21 UK newborn screening market, by technology, 2018 - 2030 (USD Million)
Table 22 UK newborn screening market, by test type, 2018 - 2030 (USD Million)
Table 23 Germany newborn screening market, by product, 2018 - 2030 (USD Million)
Table 24 Germany newborn screening market, by technology, 2018 - 2030 (USD Million)
Table 25 Germany newborn screening market, by test type, 2018 - 2030 (USD Million)
Table 26 France newborn screening market, by product, 2018 - 2030 (USD Million)
Table 27 France newborn screening market, by technology, 2018 - 2030 (USD Million)
Table 28 France newborn screening market, by test type, 2018 - 2030 (USD Million)
Table 29 Italy newborn screening market, by product, 2018 - 2030 (USD Million)
Table 30 Italy newborn screening market, by technology, 2018 - 2030 (USD Million)
Table 31 Italy newborn screening market, by test type, 2018 - 2030 (USD Million)
Table 32 Spain newborn screening market, by product, 2018 - 2030 (USD Million)
Table 33 Spain newborn screening market, by technology, 2018 - 2030 (USD Million)
Table 34 Spain newborn screening market, by test type, 2018 - 2030 (USD Million)
Table 35 Denmark newborn screening market, by product, 2018 - 2030 (USD Million)
Table 36 Denmark newborn screening market, by technology, 2018 - 2030 (USD Million)
Table 37 Denmark newborn screening market, by test type, 2018 - 2030 (USD Million)
Table 38 Sweden newborn screening market, by product, 2018 - 2030 (USD Million)
Table 39 Sweden newborn screening market, by technology, 2018 - 2030 (USD Million)
Table 40 Sweden newborn screening market, by test type, 2018 - 2030 (USD Million)
Table 41 Norway newborn screening market, by product, 2018 - 2030 (USD Million)
Table 42 Norway newborn screening market, by technology, 2018 - 2030 (USD Million)
Table 43 Norway newborn screening market, by test type, 2018 - 2030 (USD Million)
Table 44 Asia Pacific newborn screening market, by country, 2018 - 2030 (USD Million)
Table 45 Asia Pacific newborn screening market, by product, 2018 - 2030 (USD Million)
Table 46 Asia Pacific newborn screening market, by technology, 2018 - 2030 (USD Million)
Table 47 Asia Pacific newborn screening market, by test type, 2018 - 2030 (USD Million)
Table 48 Japan newborn screening market, by product, 2018 - 2030 (USD Million)
Table 49 Japan newborn screening market, by technology, 2018 - 2030 (USD Million)
Table 50 Japan newborn screening market, by test type, 2018 - 2030 (USD Million)
Table 51 China newborn screening market, by product, 2018 - 2030 (USD Million)
Table 52 China newborn screening market, by technology, 2018 - 2030 (USD Million)
Table 53 China newborn screening market, by test type, 2018 - 2030 (USD Million)
Table 54 India newborn screening market, by product, 2018 - 2030 (USD Million)
Table 55 India newborn screening market, by technology, 2018 - 2030 (USD Million)
Table 56 India newborn screening market, by test type, 2018 - 2030 (USD Million)
Table 57 Australia newborn screening market, by product, 2018 - 2030 (USD Million)
Table 58 Australia newborn screening market, by technology, 2018 - 2030 (USD Million)
Table 59 Australia newborn screening market, by test type, 2018 - 2030 (USD Million)
Table 60 Thailand newborn screening market, by product, 2018 - 2030 (USD Million)
Table 61 Thailand newborn screening market, by technology, 2018 - 2030 (USD Million)
Table 62 Thailand newborn screening market, by test type, 2018 - 2030 (USD Million)
Table 63 South Korea newborn screening market, by product, 2018 - 2030 (USD Million)
Table 64 South Korea newborn screening market, by technology, 2018 - 2030 (USD Million)
Table 65 South Korea newborn screening market, by test type, 2018 - 2030 (USD Million)
Table 66 Latin America newborn screening market, by country, 2018 - 2030 (USD Million)
Table 67 Latin America newborn screening market, by product, 2018 - 2030 (USD Million)
Table 68 Latin America newborn screening market, by technology, 2018 - 2030 (USD Million)
Table 69 Latin America newborn screening market, by test type, 2018 - 2030 (USD Million)
Table 70 Brazil newborn screening market, by product, 2018 - 2030 (USD Million)
Table 71 Brazil newborn screening market, by technology, 2018 - 2030 (USD Million)
Table 72 Brazil newborn screening market, by test type, 2018 - 2030 (USD Million)
Table 73 Mexico newborn screening market, by product, 2018 - 2030 (USD Million)
Table 74 Mexico newborn screening market, by technology, 2018 - 2030 (USD Million)
Table 75 Mexico newborn screening market, by test type, 2018 - 2030 (USD Million)
Table 76 Argentina newborn screening market, by product, 2018 - 2030 (USD Million)
Table 77 Argentina newborn screening market, by technology, 2018 - 2030 (USD Million)
Table 78 Argentina newborn screening market, by test type, 2018 - 2030 (USD Million)
Table 79 Middle East & Africa newborn screening market, by country, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa newborn screening market, by product, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa newborn screening market, by technology, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa newborn screening market, by test type, 2018 - 2030 (USD Million)
Table 83 South Africa newborn screening market, by product, 2018 - 2030 (USD Million)
Table 84 South Africa newborn screening market, by technology, 2018 - 2030 (USD Million)
Table 85 South Africa newborn screening market, by test type, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia newborn screening market, by product, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia newborn screening market, by technology, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia newborn screening market, by test type, 2018 - 2030 (USD Million)
Table 89 UAE newborn screening market, by product, 2018 - 2030 (USD Million)
Table 90 UAE newborn screening market, by technology, 2018 - 2030 (USD Million)
Table 91 UAE newborn screening market, by test type, 2018 - 2030 (USD Million)
Table 92 Kuwait newborn screening market, by product, 2018 - 2030 (USD Million)
Table 93 Kuwait newborn screening market, by technology, 2018 - 2030 (USD Million)
Table 94 Kuwait newborn screening market, by test type, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Newborn Screening market segmentation
Fig. 8 Market snapshot, 2022
Fig. 9 Market trends & outlook
Fig. 10 Market driver relevance analysis (current & future impact)
Fig. 11 Market restraint relevance analysis (current & future impact)
Fig. 12 PESTEL analysis
Fig. 13 Porter’s five forces analysis
Fig. 14 Global newborn screening market: Product movement analysis
Fig. 15 Global newborn screening market, for instruments, 2018 - 2030 (USD Million)
Fig. 16 Global newborn screening market, for reagents, 2018 - 2030 (USD Million)
Fig. 17 Global newborn screening market: Technology movement analysis
Fig. 18 Global newborn screening market, for tandem mass spectrometry, 2018 - 2030 (USD Million)
Fig. 19 Global newborn screening market, for pulse oximetry, 2018 - 2030 (USD Million)
Fig. 20 Global newborn screening market, for enzyme based assay technology, 2018 - 2030 (USD Million)
Fig. 21 Global newborn screening market, for DNA assays technology, 2018 - 2030 (USD Million)
Fig. 22 Global newborn screening market, for electrophoresis technology, 2018 - 2030 (USD Million)
Fig. 23 Global newborn screening market, for other technologies, 2018 - 2030 (USD Million)
Fig. 24 Global newborn screening market: Test type movement analysis
Fig. 25 Global newborn screening market, for Dry blood spot test, 2018 - 2030 (USD Million)
Fig. 26 Global newborn screening market, for CCHD, 2018 - 2030 (USD Million)
Fig. 27 Global newborn screening market, for Hearing Screen, 2018 - 2030 (USD Million)
Fig. 28 Regional marketplace: Key takeaways
Fig. 29 Regional outlook, 2022 & 2030
Fig. 30 Global newborn screening market: Regional movement analysis
Fig. 31 North America newborn screening market, 2018 - 2030 (USD Million)
Fig. 32 U.S. newborn screening market, 2018 - 2030 (USD Million)
Fig. 33 Canada newborn screening market, 2018 - 2030 (USD Million)
Fig. 34 Europe newborn screening market, 2018 - 2030 (USD Million)
Fig. 35 Germany newborn screening market, 2018 - 2030 (USD Million)
Fig. 36 UK newborn screening market, 2018 - 2030 (USD Million)
Fig. 37 France newborn screening market, 2018 - 2030 (USD Million)
Fig. 38 Italy newborn screening market, 2018 - 2030 (USD Million)
Fig. 39 Spain newborn screening market, 2018 - 2030 (USD Million)
Fig. 40 Denmark newborn screening market, 2018 - 2030 (USD Million)
Fig. 41 Sweden newborn screening market, 2018 - 2030 (USD Million)
Fig. 42 Norway newborn screening market, 2018 - 2030 (USD Million)
Fig. 43 Asia Pacific newborn screening market, 2018 - 2030 (USD Million)
Fig. 44 Japan newborn screening market, 2018 - 2030 (USD Million)
Fig. 45 China newborn screening market, 2018 - 2030 (USD Million)
Fig. 46 India newborn screening market, 2018 - 2030 (USD Million)
Fig. 47 Australia newborn screening market, 2018 - 2030 (USD Million)
Fig. 48 South Korea newborn screening market, 2018 - 2030 (USD Million)
Fig. 49 Thailand newborn screening market, 2018 - 2030 (USD Million)
Fig. 50 Latin America newborn screening market, 2018 - 2030 (USD Million)
Fig. 51 Brazil newborn screening market, 2018 - 2030 (USD Million)
Fig. 52 Mexico newborn screening market, 2018 - 2030 (USD Million)
Fig. 53 Argentina newborn screening market, 2018 - 2030 (USD Million)
Fig. 54 Middle East and Africa newborn screening market, 2018 - 2030 (USD Million)
Fig. 55 South Africa newborn screening market, 2018 - 2030 (USD Million)
Fig. 56 Saudi Arabia newborn screening market, 2018 - 2030 (USD Million)
Fig. 57 UAE newborn screening market, 2018 - 2030 (USD Million)
Fig. 58 Kuwait newborn screening market, 2018 - 2030 (USD Million)

★調査レポート[世界の新生児スクリーニング市場（2023-2030）：技術別（タンデム質量分析、パルスオキシメトリ）、検査種類別、製品別（装置、試薬）、地域別] (コード：GRV23NOV176)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の新生児スクリーニング市場（2023-2030）：技術別（タンデム質量分析、パルスオキシメトリ）、検査種類別、製品別（装置、試薬）、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の体外大腸がんスクリーニング検査市場（2023-2030）：検査種類別（便潜血検査、バイオマーカー検査、CRC DNAスクリーニング検査）、地域別
  • 世界の内分泌検査市場2023-2030：検査種類別（FSH、インスリン）、技術別（タンデム質量分析、イムノアッセイ）、エンドユーザー別、地域別
  • 世界の前立腺がん診断薬市場（2023-2030）：検査種類別（予備検査、確認検査）、種類別（腺がん、間質細胞がん）、エンドユーザー別（病院、外来施設）、地域別
  • 世界の細胞健康スクリーニング市場2023-2030：検査種類別（単一検査パネル、複数検査パネル）、サンプル種類別（血液、血清尿、唾液）、採取場所別、地域別
  • 世界の結核診断市場（2023-2030）：検査種類別（放射線法、臨床検査法、核酸検査、ファージアッセイ）、エンドユーザー別、地域別
  • 世界の医薬品無菌性試験市場（2023-2030）：製品種類別（装置、サービス）、種類別（アウトソーシング、インハウス）、検査種類別、サンプル別、エンドユーザー別、地域別
  • 世界のロボット支援内視鏡市場（2023-2030）：用途別（病院、外来施設）、地域別（北米、アジア太平洋、ヨーロッパ、中南米、中東・アフリカ）
  • 世界のペプチド薬物複合体（PDC）市場（2023-2030）：製品別（ルテチウム、メルフルフェン、ANG1005、BT1718、CBX-12、その他）、種類別（診断薬、治療薬）、地域別
  • 世界の鉄欠乏性貧血（IDA）治療市場（2023-2030）：治療種類別（経口鉄剤治療、非経口鉄剤治療）、年齢層別、エンドユーザー別、地域別
  • 世界の網膜静脈閉塞症治療市場（2023-2030）：エンドユーザー別（小売薬局、病院・診療所）、疾患種類別（CRVO、BRVO）、治療薬別（抗VEGF薬、副腎皮質ステロイド薬）、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆